Alzheimer’s study looks to BYOD tech

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/Ocskaymark)
(Image: Getty/Ocskaymark)

Related tags Datacubed Health BYOD Alzheimer's disease Clinical trials Technology

Datacubed Health’s mobile platform has been selected to support a longitudinal Alzheimer’s study aimed at better understanding the disease and finding effective treatments.

The global studies will involve those at risk of Dominantly Inherited Alzheimer’s Disease (DIAD), a rare form of early-onset Alzheimer’s Disease.

Datacubed’s Linkt platform will be used to collect real-time data on sleep, diet, and other biomarkers using a “bring your own device” (BYOD) study model, according to the company.

“Datacubed Health’s tools allow researchers and study coordinators to enroll participants, monitor real-time progress and compliance dashboards, manage incentives, and review study data, and link these with detailed information collected during traditional in-person research assessments,”​ said Eric McDade, Principal Investigator for the DIAN Expanded Registry.

The study will include individuals with confirmed or suspected DIAD in their families and is being conducted by scientists at the Dominantly Inherited Alzheimer Network (DIAN) at the Washington University School of Medicine in Saint Louis.

“In Alzheimer's, it is critical to move scheduling information and tasks remotely so that patient burden can be minimized and the adoption of real-world settings can be realized,”​ said David Kiger, Datacubed Health CCO.

The research will incorporate an observational study, clinical drug trials, a research registry, as well as other, smaller, ancillary studies.

McDade told us, “The goals of the study are to collect relevant information from participants in DIAN related studies that can help in understand the disease and lead to effective treatments.”

Moving forward the study will examine additional outcomes, “such as those input by caregivers for collateral sources to report on research participants,”​ said McDade. Researchers also will track additional data, like sleep measure, and identify alternative ways to remotely collect trial data.

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

2023 State of Clinical Trial Technology Report

2023 State of Clinical Trial Technology Report

Florence Healthcare | 01-Mar-2023 | Insight Guide

Discover the trends shaping clinical trial technology in 2023, from Site Enablement to eISFs, integrations, and site-sponsor collaboration. This report...

Related suppliers

Follow us

Products

View more

Webinars